Elotuzumab
AbbVie,BMS
['mmsm', 'elotuzumab', 'krd ']
#asco23 #mmsm plasma cell dyscrasia oral session krd vs. elotuzumab+krd setting:transplant-eligible, newly diagnosed myeloma presentation: post induction phase results(first primary endpoint) primary endpoint: rate of pts who were in vgpr+mrd -ve 
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities